10-Q: American Healthcare REIT Posts Strong Q2 Earnings

American Healthcare REIT reported significant increases in net income, FFO, and NOI for Q2 2025, driven by improved resident occupancy and lower interest expenses, despite real estate impairments.

Summary

• Net income attributable to controlling interest increased to $9.9 million for the three months ended June 30, 2025, up from $2.0 million in the prior year period.
• For the six months ended June 30, 2025, net income attributable to controlling interest was $3.1 million, a significant improvement from a net loss of $1.9 million in the same period of 2024.
• Total revenues for the three months ended June 30, 2025, reached $542.5 million, an increase from $504.6 million in the prior year, primarily due to higher resident fees and services.
• Total revenues for the six months ended June 30, 2025, were $1,083.1 million, up from $1,004.1 million in the same period of 2024.
• NAREIT FFO attributable to controlling interest rose to $66.8 million for Q2 2025, compared to $41.7 million for Q2 2024.
• Normalized FFO attributable to controlling interest increased to $68.4 million for Q2 2025, from $43.7 million for Q2 2024.
• Net Operating Income (NOI) for Q2 2025 was $103.2 million, an increase from $88.7 million in Q2 2024.
• The company recognized an aggregate impairment charge of $12.7 million for five Outpatient Medical (OM) buildings for the three months ended June 30, 2025, and $34.4 million for six OM buildings for the six months ended June 30, 2025.
• Disposed of one Senior Housing Operating Property (SHOP), two Integrated Senior Health Campuses (ISHC), and three OM buildings for a total net loss of $3.0 million during the six months ended June 30, 2025.
• Acquired nine land parcels in Indiana for $250,000 for future ISHC development, one previously leased real estate investment in Indiana for $16.1 million, and one SHOP in Virginia for $65.0 million during the six months ended June 30, 2025.
• Issued 7,028,690 shares of Common Stock under the At-The-Market (ATM) Offering for gross proceeds of $236.3 million during the six months ended June 30, 2025.
• The Trilogy Credit Facility was repaid and terminated on March 3, 2025.
• As of June 30, 2025, the company had $550.0 million outstanding under its line of credit and term loan, with $600.0 million remaining available.
• The weighted average effective interest rate on outstanding debt, factoring in interest rate swaps, was 4.33% as of June 30, 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong financial improvements across key metrics like net income, FFO, and NOI, coupled with effective debt reduction. However, significant real estate impairments in the OM segment and the emergence of new regulatory risks, particularly the potential impact of Medicaid spending cuts, introduce notable uncertainties that temper the overall positive outlook.

Positives

• Net income attributable to controlling interest significantly improved to $9.9 million for Q2 2025, from $2.0 million in Q2 2024, and shifted from a loss to a gain for the six-month period.
• Basic and diluted earnings per share increased to $0.06 for Q2 2025, up from $0.01 in Q2 2024, and turned positive for the six-month period.
• Total revenues increased by 7.5% for Q2 2025 and 7.9% for the six months ended June 30, 2025, driven by growth in resident fees and services.
• NAREIT FFO and Normalized FFO attributable to controlling interest saw substantial increases, indicating improved operational performance.
• Net Operating Income (NOI) increased by 16.4% for Q2 2025 and 15.7% for the six months ended June 30, 2025, reflecting better property-level profitability.
• Interest expense, net, decreased by $7.9 million for Q2 2025 and $21.5 million for the six months ended June 30, 2025, primarily due to lower debt balances from equity offerings.
• Resident occupancy rates improved for Integrated Senior Health Campuses (ISHC) to 89.4% (from 87.0%) and Senior Housing Operating Properties (SHOP) to 87.0% (from 85.5%) year-over-year.
• The company successfully raised $236.3 million in gross proceeds through its ATM Offering during the first six months of 2025, enhancing liquidity and facilitating debt reduction.
• The Trilogy Credit Facility was fully repaid and terminated, simplifying the debt structure and reducing associated obligations.

Negatives

• Real estate revenue decreased by $5.3 million for Q2 2025 and $9.3 million for the six months ended June 30, 2025, primarily due to dispositions of triple-net leased properties and OM buildings.
• The company recognized significant impairment charges on real estate investments totaling $12.7 million for Q2 2025 and $34.4 million for the six months ended June 30, 2025, related to Outpatient Medical (OM) buildings.
• A net loss in the fair value of derivative financial instruments of $0.6 million for Q2 2025 and $1.4 million for the six months ended June 30, 2025, compared to gains in the prior year periods, negatively impacted other income/expense.
• Loss on dispositions of real estate investments increased to $2.7 million for Q2 2025 and $3.0 million for the six months ended June 30, 2025, compared to minimal or gain in prior periods.
• Weighted average leased percentage for non-RIDEA properties decreased to 89.0% as of June 30, 2025, from 91.3% as of June 30, 2024.

Risks

• The use of, or inability to use, artificial intelligence (AI) by the company, its operators, tenants, and vendors presents risks including inaccuracy, bias, infringement or misappropriation of intellectual property, and data privacy and cybersecurity concerns.
• Cybersecurity threat actors may utilize AI tools to automate and enhance attacks, posing significant risks to data security and systems.
• Investors, analysts, and other market participants using AI tools to process or interpret financial information could lead to inaccurate conclusions or investment recommendations.
• Changes in federal, state, or local laws or regulations, including those limiting REIT investment in healthcare or reducing healthcare-related tax benefits, could adversely affect the business.
• The One Big Beautiful Bill Act (OBBBA), signed on July 4, 2025, includes an estimated $1 trillion in cuts to Medicaid spending, which could potentially adversely impact financial performance through work requirements, patient cost-sharing, and phasedown of provider taxes and state-directed payments.

Future Outlook

The company expects continued inflationary pressures to impact profitability in its ISHC and SHOP segments, but aims to offset this through higher resident fees and care fee increases, as well as adjusting market rates. For non-RIDEA properties, negotiated rental increases and expense reimbursements are expected to mitigate inflation. The company plans to continue its leasing strategy focusing on renewals and identifying new tenants. It believes its current liquidity sources, including cash flows from operations, equity issuances, and available credit, will be sufficient to meet cash requirements for the next 12 months and beyond, including debt service, capital expenditures, and stockholder distributions.

Management Comments

• Inflation has impacted operations, leading to increases in the cost of labor, services, energy, and supplies, particularly in ISHC and SHOP segments.
• RIDEA managers have been directed to bill higher than average annual rent and care fee increases for existing residents in 2024 and 2025 to offset inflation.
• Market rates are being adjusted as frequently as needed based on competitor pricing and market conditions to improve operating performance and increase rent coverage.
• The company believes its practice of adjusting rates will improve operating performance in ISHC and SHOP, and increase rent coverage and stability of real estate revenue in triple-net leased properties over time.
• The company is in compliance with all financial and non-financial covenants on its mortgage loans payable and credit facility as of June 30, 2025.

Industry Context

The healthcare real estate sector continues to navigate inflationary pressures, particularly impacting labor, services, energy, and supplies. American Healthcare REIT's strategy of increasing resident fees and adjusting market rates aligns with broader industry efforts to manage rising operational costs. The legislative changes introduced by the One Big Beautiful Bill Act (OBBBA), specifically the estimated $1 trillion in Medicaid spending cuts, represent a significant regulatory shift that could impact the financial performance of healthcare providers and, by extension, healthcare REITs. The permanent extension of the 20% deduction for qualified REIT dividends and the increased TRS asset test limit are favorable for REITs, but the Medicaid cuts introduce a new layer of uncertainty for the sector's revenue streams, especially for facilities reliant on government payors.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• Not presently subject to any material litigation, nor is any material litigation threatened, that would have a material adverse effect on consolidated financial position, results of operations, or cash flows.

Related Party Transactions

• AHI Group Holdings, LLC (owned and controlled by Jeffrey T. Hanson, Danny Prosky, and Mathieu B. Streiff) and a wholly owned subsidiary of Griffin Capital Company, LLC owned 1.2% and 1.3% of the operating partnership units as of June 30, 2025, and December 31, 2024, respectively.

Stakeholder Impact

• Shareholders: Positive impact from increased net income, FFO, and NOI, and continued distributions. Potential impact from new legislative risks and real estate impairments.
• Employees: Benefit from continued equity compensation plans (AHR Incentive Plan, ESPP) and potential future Manager Equity Plan awards for RIDEA managers.
• Customers (Residents/Tenants): Impacted by increased resident fees and care charges to offset inflation, and potential changes in services due to Medicaid cuts.
• Creditors: Positive impact from debt reduction and compliance with loan covenants, indicating improved financial health and reduced default risk.
• Suppliers: Potential impact from inflationary pressures on costs of services and supplies, which the company is actively managing.

Next Steps

• Continue to fund property operating expenses and general and administrative expenses.
• Meet debt service requirements (principal and interest).
• Fund the acquisition of real estate investments, development activities, and capital expenditures.
• Make distributions to stockholders to maintain REIT qualification.
• Evaluate the impact of the newly adopted ASU 2024-03 and ASU 2025-01 on financial statement disclosures, effective for annual reporting periods beginning after December 15, 2026.
• Evaluate the impact of ASU 2025-03 on consolidated financial statements and disclosures, effective for annual reporting periods beginning after December 15, 2026.

Key Dates

Recommendation

While American Healthcare REIT demonstrated strong financial improvements in net income, FFO, and NOI, driven by increased resident occupancy and effective debt management, the significant real estate impairments on OM buildings and the introduction of new regulatory risks, particularly the estimated $1 trillion in Medicaid spending cuts from the OBBBA, introduce considerable uncertainty. The company's proactive capital raising efforts are positive, but the mixed operational performance across segments and potential future headwinds warrant a cautious 'hold' stance for seasoned investors, allowing time to assess the full impact of these new risks and the sustainability of improvements in the OM segment.

Keywords

Healthcare REIT, Senior Housing, Outpatient Medical, Real Estate, REIT, Healthcare, Investment, Property Management, SEC Filing, 10-Q